Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing 4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate in Europe. Original Data : EMA Website

Menu
$ API Ref.Price (USD/KG) : 653Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1SANOFI-AVENTIS SpA

02 1EG SpA

03 1MYLAN SpA

04 2Nico Brand Ltd

05 1Nicobrand Limited

06 1Teva Pharma AG

07 2Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ISPE Annual Meeting
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Oxybutynin

Brand Name : Ditropan

Dosage Form :

Dosage Strength : 30 Cpr 5 Mg  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

02

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutyninum

Brand Name : Kentera

Dosage Form : Matrixpfl

Dosage Strength : 3.9mg/24h

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name : Sibutinina Hydrochloride

Dosage Form : Oxybutynin Hydrochloride 5Mg 30 Joined' Oral Use

Dosage Strength : 30 CPR 5 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

Nicobrand Limited

Country
2024 ISPE Annual Meeting
Not Confirmed
arrow

Nicobrand Limited

Country
arrow
2024 ISPE Annual Meeting
Not Confirmed

oxybutynin

Brand Name : Kentera

Dosage Form : TRANSDERMAL PATCH

Dosage Strength : 3.9 MG / 24 HOURS

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

05

EG SpA

Country
2024 ISPE Annual Meeting
Not Confirmed
arrow

EG SpA

Country
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name : Oxybutynin

Dosage Form : Oxybutynin Hydrochloride 5Mg 30 Joined' Oral Use

Dosage Strength : 30 CPR 5 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

Country
2024 ISPE Annual Meeting
Not Confirmed
arrow

Country
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name : Dresplan 5Mg 60 Tablets

Dosage Form : Tablet

Dosage Strength : 5 Mg/Tablet

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

07

Country
2024 ISPE Annual Meeting
Not Confirmed
arrow

Country
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name : Ditropan 5Mg 60 Tablets

Dosage Form : Tablet

Dosage Strength : 5 Mg/Tablet

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

08

Nico Brand Ltd

Country
2024 ISPE Annual Meeting
Not Confirmed
arrow

Nico Brand Ltd

Country
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name : Kentera

Dosage Form : Transdermal patches

Dosage Strength : 3.9 mg/24 hours

Packaging : Calendar Gasket

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

Nico Brand Ltd

Country
2024 ISPE Annual Meeting
Not Confirmed
arrow

Nico Brand Ltd

Country
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name : Kentera

Dosage Form : Transdermal patches

Dosage Strength : 3.9 mg/24 hours

Packaging : Calendar Gasket

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank